e-learning
resources
ERS Research Seminars
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cystic Fibrosis Lung disease, from animal models to experimental therapeutics.
B. Scholte (Rotterdam, The Netherlands)
Source:
Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Number:
1
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Scholte (Rotterdam, The Netherlands). Cystic Fibrosis Lung disease, from animal models to experimental therapeutics.. Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Modelling and simulation of experimental designs to find the best design of randomized clinical trials in a rare disease: Cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Cystic fibrosis lung disease assessed by lung clearance index
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
A new gold standard for assessing CT in early CF lung disease?
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014
Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
What is a NICE definition of lung disease in patients with Cystic Fibrosis and its impact on treatment?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Evaluation of Idiopathic Pulmonary Fibrosis therapies, Pirfenidone and Nintedanib, in a Human Experimental Model of Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
Source: International Congress 2014 – ILDs 4
Year: 2014
Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
The burden of sinus disease in CF candidates for lung transplantation
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
The role of
CFTR/ENaC
genotype in cystic fibrosis-like phenotypes
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
Adaptation of
prevotella
during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017
Genetics, pathophysiology and diagnosis of Cystic fibrosis
Source: ERS Skills Course 2016
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept